Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease

from The Lancet in conversation with · host The Lancet Group

Michael Heneka joins Chloe Wilson and Bea Gomez Perez-Nievas of The Lancet to discuss a therapeutics paper discussing the opportunities and challenges of passive anti-amyloid β immunotherapy in Alzheimer's disease. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01883-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Episode metadata supplied by the publisher feed · Published Jan 9, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease

0:00 21:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Lancet in conversation with?

This episode is 21 minutes long.

When was this The Lancet in conversation with episode published?

This episode was published on January 9, 2025.

Can I download this The Lancet in conversation with episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!